Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08LQS
|
|||
| Drug Name |
ETBX-021
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [1], [2], [3] | |
| Company |
Etubics Seattle, WA NantBioScience Culver City, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.